ESP vs Retrolaminar Block: A Randomized Trial | MicrobiomeTrials← Back to trialsNCT07200960
ESP vs Retrolaminar Block: A Randomized Trial
CompletedNAINTERVENTIONAL
Trial Details
Start: 2022-02-01Est. Completion: 2024-09-01
Enrollment target: 90 participants Locations- Shaukat Khanum Memorial Cancer Hospital & Research Centre., Lahore, Punjab Province, Pakistan
Other microbiome trials you might be interested in
Chronic Pain
The goal of this study is to ask chronic pain patients their preferences regarding which side effects of pain medication…
Brussels, BelgiumEst. completion Jul 31, 2027
Postoperative Pain
It is already known that fascia iliaca compartment block and intrathecal nalbuphine are very effective ways in postopera…
Cairo, EgyptEst. completion Oct 31, 2026
Older Adults
Hip Fracture Surgery
Fascia Iliaca Block
Liposomal Bupivacaine
Postoperative Pain
Older patients with hip fractures often suffer from severe pain. Inadequate analgesia increases the risk of postoperativ…
Beijing, ChinaEst. completion Jun 2028